CorMedix (CRMD) Retained Earnings (2016 - 2025)
CorMedix (CRMD) has disclosed Retained Earnings for 13 consecutive years, with -$176.6 million as the latest value for Q4 2025.
- Quarterly Retained Earnings fell 194138.46% to -$176.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$176.6 million through Dec 2025, down 194138.46% year-over-year, with the annual reading at -$176.6 million for FY2025, 194138.46% down from the prior year.
- Retained Earnings hit -$176.6 million in Q4 2025 for CorMedix, up from -$190.6 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $99181.0 in Q2 2021 to a low of -$336.2 million in Q1 2024.
- Historically, Retained Earnings has averaged -$125.6 million across 5 years, with a median of $82743.0 in 2022.
- Biggest five-year swings in Retained Earnings: surged 100.05% in 2021 and later crashed 349049.8% in 2025.
- Year by year, Retained Earnings stood at $87130.0 in 2021, then decreased by 5.04% to $82743.0 in 2022, then rose by 2.0% to $84399.0 in 2023, then grew by 7.82% to $91000.0 in 2024, then plummeted by 194138.46% to -$176.6 million in 2025.
- Business Quant data shows Retained Earnings for CRMD at -$176.6 million in Q4 2025, -$190.6 million in Q3 2025, and -$299.2 million in Q2 2025.